Why should intramuscular anti‐D be different from intravenous anti‐D?
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18524
Abstract: For reasons of safety the use of intravenous anti D to treat ITP has largely been abandoned because of the risk it incurs of intravascular haemolysis. Intramuscular delivery of anti‐D could be a safer approach… read more here.
Keywords: intramuscular anti; anti different; risk; intravenous anti ... See more keywords